文献速递术前评估与围术期医学疼痛医学

非阿片类药物围术期干预慢性术后疼痛的荟萃分析质量系统评价

Quality of meta-analyses of non-opioid, pharmacological, perioperative interventions for chronic postsurgical pain: a systematic review.
PubMed 文献 · Reg Anesth Pain Med · 2022-01-13

该系统评价检索了2010至2020年发表的17篇荟萃分析,评估非阿片类药物围术期干预对成人慢性术后疼痛发生率的影响,并用AMSTAR 2工具评价其方法学质量。结果显示88.2%(15/17)的研究质量为低或极低,最常见的缺失要素是发表偏倚分析,趋势提示质量随时间及期刊影响因子有所改善,但仍需高质量荟萃分析。

要点

  • 88.2%(15/17)的荟萃分析质量为低或极低。
  • 最常见的缺失关键要素是发表偏倚分析。
  • 仍需高质量荟萃分析指导慢性术后疼痛围术期管理。

核心结论

  • 尽管已有多次尝试,针对非阿片类药物围术期干预慢性术后疼痛的荟萃分析质量仍多不理想,亟需高质量研究。

研究设计与样本

  • 系统评价:检索Embase、MEDLINE和Cochrane系统评价数据库,纳入2010至2020年发表的17篇荟萃分析,用AMSTAR 2工具评价方法学质量。

主要发现

  • 17篇研究共进行了58项荟萃分析,涉及加巴喷丁类、氯胺酮、利多卡因、非甾体抗炎药和 mexiletine。
  • 根据AMSTAR 2,88.2%(15/17)的研究质量为低或极低。
  • 最常见的缺失关键要素是发表偏倚分析。
  • 趋势提示质量随时间改善并与期刊影响因子相关。

关键数值与推荐

  • AMSTAR 2评价显示88.2%(15/17)的研究为低或极低质量。

临床怎么用

  • 临床解读相关荟萃分析时需警惕其方法学质量,尤其注意是否进行了发表偏倚分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In an attempt to aggregate observations from clinical trials, several meta-analyses have been published examining the effectiveness of systemic, non-opioid, pharmacological interventions to reduce the incidence of chronic postsurgical pain. OBJECTIVE: To inform the design and reporting of future studies, the purpose of our study was to examine the quality of these meta-analyses. EVIDENCE REVIEW: We conducted an electronic literature search in Embase, MEDLINE, and the Cochrane Database of Systematic Reviews. Published meta-analyses, from the years 2010 to 2020, examining the effect of perioperative, systemic, non-opioid pharmacological treatments on the incidence of chronic postsurgical pain in adult patients were identified. Data extraction focused on methodological details. Meta-analysis quality was assessed using the A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR 2) critical appraisal tool. FINDINGS: Our search yielded 17 published studies conducting 58 meta-analyses for gabapentinoids (gabapentin and pregabalin), ketamine, lidocaine, non-steroidal anti-inflammatory drugs, and mexiletine. According to AMSTAR 2, 88.2% of studies (or 15/17) were low or critically low in quality. The most common critical element missing was an analysis of publication bias. Trends indicated an improvement in quality over time and association with journal impact factor. CONCLUSIONS: With few individual trials adequately powered to detect treatment effects, meta-analyses play a crucial role in informing the perioperative management of chronic postsurgical pain. In light of this inherent value and despite a number of attempts, high-quality meta-analyses are still needed. PROSPERO REGISTRATION NUMBER: CRD42021230941.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. McGregor RH, Warner FM, Linde LD, et al. Quality of meta-analyses of non-opioid, pharmacological, perioperative interventions for chronic postsurgical pain: a systematic review. Reg Anesth Pain Med. 2022. PMID: 35027479. doi:10.1136/rapm-2021-102981

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。